IJR News — today's news from every sideVolvo Wheel Loader and Classic Wagons Appear in Listings — Sep 11, 2026Volvo’s current lineup and collectors’ market highlight a mix of practicality and performance: the L150H wheel loader under the H-series is designed for durable, productive material handling in demanding sites, while the 2025 V90 Cross Country offers a high-end, car-like wagon with mild-hybrid power and rugged styling for those seeking wagon versatility over SUVs; the 1995 Volvo 850 T-5R, though rare and heavily modified to a manual, remains highly sought after with ongoing strong valuation and detailed maintenance history. In older Volvo lore, the 960 estate stands out for its large size, robust straight-six engine, rear-wheel drive, and ongoing considerations of running costs in today’s market.
Elena Vasquez The 850 T-5R values holding up even modified tells me the right examples are still worth chasing.Elena Vasquez Modest recurring profit growth with heavy R&D spend is the real story here, the buyback is just window dressing for investors. Dr. David Crean Book Guides Biopharma Leaders on Commercialization — Sep 18, 2026A new book, Dual Fluency: Bridging Science, Capital, and Governance in Life Sciences by Dr. David H. Crean, offers a practical blueprint for biopharma to move from discovery to commercialization by focusing on three core translations—Data to Capital, Discovery to Deal, and Bench to Boardroom—along with Capital Stack Optimization. Aimed at scientist-founders, pre-commercial CEOs, BD executives, and investors, the work promises actionable risk-reduction insights and will be available on Amazon and major bookstores through Cardiff Advisory LLC.
Jared Kim This book seems helpful for scientist founders who struggle turning research into actual funding and governance plans.Tom Gallagher Employers in tech will face more turnover costs and delays when trying to fill specialized roles.